By Zacks Equity Research  AG NVS announced that the FDA has approved its arthritis drug, Cosentyx (secukinumab), in two new indications – for the treatment of adults with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA). The approvals came on the back of positive efficacy and safety outcomes from four placebo-controlled phase III studies.… Read More

PALO ALTO, Calif.–(BUSINESS WIRE)–Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of crisaborole topical ointment, 2%, a novel non-steroidal topical anti-inflammatory phosphodiesterase-4 (PDE-4) inhibitor in development for the potential treatment of mild-to-moderate atopic dermatitis in children and adults.… Read More

Our skin is the largest organ of our body, making skincare a multi-billion dollar industry.  Shelves are stocked full of products for the treatment and papering of our skin.  Creams and oils claiming to turn back the clock and remove wrinkles, ointments for warts, Eczema, or other conditions, and more lotions than you can imagine… Read More